HALO reported record revenue of $326 million and raised 2025 guidance, leading to a 41% year-over-year rise in earnings. Big Money investors are heavily betting on the stock, with institutional support and strong sales and earnings growth. EPS is estimated to increase by +30.6% this year, attracting more interest. Halozyme has been a top-rated stock, drawing 23 outlier inflow signals since 2019 and gaining 491% since Big Money first got involved. The stock’s historical gains and strong fundamentals make it a potential addition to a diversified portfolio.

Read more at Yahoo Finance: Identify Superstar Stocks Like Halozyme with Money Flows